NCT02458885

Brief Summary

Aim of investigators is to conduct a registry of acute myocardial infarction including a broad network of critical care / coronary care unit throughout Argentina to increase the knowledge about treatments, timing of reperfusion therapy and outcomes, both in-hospital and during short-term follow up.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2015

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2015

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

May 26, 2015

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 1, 2015

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2015

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2015

Completed
Last Updated

June 3, 2015

Status Verified

June 1, 2015

Enrollment Period

5 months

First QC Date

May 26, 2015

Last Update Submit

June 2, 2015

Conditions

Keywords

myocardial infarctionobservational registrymortality

Outcome Measures

Primary Outcomes (3)

  • Appropriate use of reperfusion therapy

    Timely initiation of reperfusión (door to needle time \<30 minutes or door to balloon time \<90 minutes).

    In-hospital, with an expected average of 5 days.

  • In-hospital mortality

    All cause death during initial hospitalization.

    In-hospital, with an expected average of 5 days.

  • All cause mortality

    All cause mortality between symptoms onset and 30 days.

    30 days.

Secondary Outcomes (1)

  • In-hospital complications

    In-hospital, with an expected average of 5 days.

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with ST elevation Myocardial infarction.

You may qualify if:

  • Patients admitted with AMI and ST-segment elevation.
  • AMI evolved with new Q waves less than 36 hours evolution.
  • Suspected inferoposterior AMI (horizontal ST depression in V1 to V3, suggestive of acute circumflex coronary artery occlusion).
  • New or presumed new left bundle branch block.

You may not qualify if:

  • Acute coronary syndrome without ST elevation or non-Q AMI
  • Myocardial infarction of more than 36 hours of evolution.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sociedad Argentina de Cardiología

Ciudad Autónoma de Buenos Aires, Buenos Aires, 1115, Argentina

RECRUITING

MeSH Terms

Conditions

Myocardial Infarction

Condition Hierarchy (Ancestors)

Myocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesInfarctionIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosis

Study Officials

  • Juan Gagliardi, PhD

    +54 114961-6027

    STUDY CHAIR

Central Study Contacts

Carlos D Tajer, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
30 Days
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 26, 2015

First Posted

June 1, 2015

Study Start

April 1, 2015

Primary Completion

September 1, 2015

Study Completion

October 1, 2015

Last Updated

June 3, 2015

Record last verified: 2015-06

Locations